A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.

@article{Ahmed2016AMA,
  title={A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.},
  author={M. Ahmed and R. Kartha and R. Brundage and J. Cloyd and C. Basu and B. Carlin and R. Jones and A. Moser and A. Fatemi and G. Raymond},
  journal={British journal of clinical pharmacology},
  year={2016},
  volume={81 6},
  pages={
          1058-66
        }
}
AIMS X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder, most commonly affecting boys, associated with increased very long chain fatty acids (C26:0) in all tissues, causing cerebral demyelination and adrenocortical insufficiency. Certain monounsaturated long chain fatty acids including oleic and erucic acids, known as Lorenzo's oil (LO), lower plasma C26:0 levels. The aims of this study were to characterize the effect of LO administration on plasma C26:0 concentrations and to… Expand
3 Citations
Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders
  • 16
Orphan drug development: the increasing role of clinical pharmacology
  • 5

References

SHOWING 1-10 OF 24 REFERENCES
Dietary erucic acid therapy for X‐linked adrenoleukodystrophy
  • 182
A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
  • 200
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
  • 76
X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
  • 192
  • PDF
Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls
  • 255
X-linked adrenoleukodystrophy.
  • 274
  • PDF
Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
  • 17
...
1
2
3
...